Re-Discovering PDE3 Inhibitors - New Opportunities for a Long Neglected Target

E-ISSN： 1873-4294|7|4|421-436

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.7, Iss.4, 2007-02, pp. : 421-436

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of cyclic nucleotide phosphodiesterase PDE3 as adjunct therapy for dilated cardiomyopathy

By Movsesian Matthew A Alharethi Rami

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1529-1536

Informa Healthcare

Access to resources Recommend Favorite

PDE7 inhibitors as new drugs for neurological and inflammatory disorders

By Gil Carmen Campillo Nuria E Perez Daniel I Martinez Ana

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 10, 2008-10 ,pp. : 1127-1139

Informa Healthcare

Access to resources Recommend Favorite

New Therapeutic Applications of Phosphodiesterase 5 Inhibitors (PDE5-Is)

Current Medicinal Chemistry, Vol. 23, Iss. 12, 2016-05 ,pp. : 1239-1249

Bentham Science Publishers

Access to resources Recommend Favorite

Finding New Hits in Neglected Disease Projects: Target or Phenotypic Based Screening?

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 10, 2011-05 ,pp. : 1284-1291

Bentham Science Publishers

Access to resources Recommend Favorite

PDE7 inhibitors

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 601-603

Informa Healthcare

Access to resources Recommend Favorite